Form D · Biotechnology
NEWLINK GENETICS CORP
Ames, IA · CIK 0001126234
Offering snapshot reported Sep 22, 2011 · SEC filing
- Reported sold
- $12.8M Offering amount: $12.8M
- Investors reported
- 38 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 1, 2010 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$7,319,375 → $12,760,000
- Reported investors34 → 38
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 22, 2011 | Amendment | $12,760,000 | $5,440,625vs Dec 7, 2010 | 38 | SEC filing |
| Aug 17, 2011 | Amendment | $10,360,687 | $1,726,187vs Jan 31, 2011 | 40 | SEC filing |
| Jun 3, 2011 | Initial | $250,000 | No comparison | 1 | SEC filing |
| Jan 31, 2011 | Amendment | $8,634,500 | -$1,726,187vs Jan 21, 2011 | 40 | SEC filing |
| Jan 21, 2011 | Initial | $10,360,687 | No comparison | 40 | SEC filing |
| Dec 7, 2010 | Initial | $7,319,375 | No comparison | 34 | SEC filing |
| Jul 28, 2009 | Initial | $7,500,000 | No comparison | 1 | SEC filing |
| Jul 28, 2009 | Amendment | $20,714,105 | No comparison | 114 | SEC filing |
| Jan 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Aug 31, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 19, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-151494
Source: Form D, filed Sep 22, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Sarah J. Alexander, M.D. | Director |
| Paul R. Edick | Director |
| Gordon H. Link | Executive |
| Charles Link, M.D. | Director, Executive |
| David J. Lundquist | Director |
| Kenneth Lynn | Executive |
| Tom Raffin, M.D. | Director |
| Joseph Saluri | Director |
| Ernest Talarico, Iii | Director |
| Nicholas Vahanian, M.D. | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
2503 South Loop Drive Suite 5100
Ames, IA, 50010
Ames, IA, 50010